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Antibodies against EGF‑like 
domains in Ixodes scapularis BM86 
orthologs impact tick feeding 
and survival of Borrelia burgdorferi
Juraj Koči1,2,3*, Sandhya Bista1, Payal Chirania1, Xiuli Yang1, Chrysoula Kitsou1, 
Vipin Singh Rana1, Ozlem Buyuktanir Yas4, Daniel E. Sonenshine5 & Utpal Pal1,6* 
Ixodes scapularis ticks transmit multiple pathogens, including Borrelia burgdorferi sensu stricto, 
and encode many proteins harboring epidermal growth factor (EGF)‑like domains. We show that 
I. scapularis produces multiple orthologs for Bm86, a widely studied tick gut protein considered as 
a target of an anti‑tick vaccine, herein termed as Is86. We show that Is86 antigens feature at least 
three identifiable regions harboring EGF‑like domains (termed as EGF‑1, EGF‑2, and EGF‑3) and are 
differentially upregulated during B. burgdorferi infection. Although the RNA interference‑mediated 
knockdown of Is86 genes did not show any influences on tick engorgement or B. burgdorferi sensu 
stricto persistence, the immunization of murine hosts with specific recombinant EGF antigens 
marginally reduced spirochete loads in the skin, in addition to affecting tick blood meal engorgement 
and molting. However, given the borderline impact of EGF immunization on tick engorgement and 
pathogen survival in the vector, it is unlikely that these antigens, at least in their current forms, 
could be developed as potential vaccines. Further investigations of the biological significance of Is86 
(and other tick antigens) would enrich our knowledge of the intricate biology of ticks, including their 
interactions with resident pathogens, and contribute to the development of anti‑tick measures to 
combat tick‑borne illnesses.
Lyme disease, a prevalent arthropod-borne disease in North America and Europe, is caused by a bacterial 
pathogen, Borrelia burgdorferi, and is transmitted by infected Ixodes scapularis and other closely-related ticks via 
feeding on animals, including  humans1. Once transmitted to hosts, spirochetes can colonize a variety of organs, 
causing Lyme arthritis, carditis, and an array of neurological  syndromes2. Antibiotic therapy resolves clinical 
symptoms, in most cases, during the early stages of infection. However, persistent or relapsing symptoms (e.g., 
fatigue, musculoskeletal pain, and cognitive difficulties) can later develop in a subset of patients; these symptoms 
are collectively referred to as chronic Lyme disease, otherwise known as post-treatment Lyme disease syndrome 
(PTLDS)3. The underlying mechanisms, pathogenesis, and treatment of PTLDS remain  unknown4,5. Therefore, it 
is of great importance to develop a vaccine that will prevent the incidence of serious tick-borne infections such 
as Lyme borreliosis. Most research efforts focus on the identification of either B. burgdorferi antigens or tick 
proteins that are required for the survival of spirochetes within ticks, in an attempt to interfere with pathogen 
transmission from ticks or infectivity in the hosts, thereby preventing Lyme  disease6. In fact, a human vaccine 
based on a recombinant form of a B. burgdorferi outer surface protein,  OspA7, was developed and approved in 
1998 by the Federal Drug Administration, but it was later withdrawn because of sales issues and patient-related 
complications. Other strategies, such as controlling tick infestations, might serve as alternative preventive meth-
ods to reduce the incidence of Lyme disease.
Ixodes ticks can transmit pathogens to humans and cause a range of serious  diseases8. Given the lack of effec-
tive vaccines, tick-borne diseases continue to spread, impacting human and animal health on a global scale. A tra-
ditional way to combat tick-borne diseases is to control the tick population using acaricides, which are becoming 
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increasingly less effective due to the emergence of resistant tick strains. Other preventive measures, including 
tick avoidance, protective clothing, and tick repellents, are only 20–40%  effective9. Hence, current efforts have 
been geared towards the development of highly efficacious anti-tick vaccines to control tick  infestations10–12. 
Generally, anti-tick vaccine development is based on tick antigens that are accessible to host-derived antibodies, 
such as surface-exposed gut antigens. A ‘concealed’ midgut protein from Rhipicephalus (formerly Boophilus) 
microplus cattle ticks, termed as Bm86, is expressed specifically in the tick midgut with upregulation during 
 feeding13; it has been used as a commercially available anti-tick vaccine to induce effective protection in cattle 
against R. microplus infestation. Although the precise function of Bm86 has not been described, the vaccine 
impairs the survival of ticks on immunized cattle and substantially reduces engorgement weights, which is 
caused by a disruption of the tick midgut epithelium, suggesting Bm86′s role in the development of tick midgut 
tissue during the engorgement  process14,15. The Bm86-based vaccine can also affect the egg-laying capacities of 
surviving ticks. Notably, besides reducing tick populations, Bm86-based vaccines have the potential to partially 
block the transmission of tick-borne pathogens like Babesia ovis16,17. Despite their promise as anti-tick vaccines 
for cattle, vaccination with Bm86 orthologs in I. ricinus ticks (Ir86-1 and Ir86-2) did not show obvious effects 
on the feeding parameters of I. ricinus18,19, suggesting that certain species of ticks may be refractory to the Bm86 
vaccine, and that immunization with the whole protein (which was the case with the I. ricinus orthologs) may 
induce immunodominant but non-neutralizing antibodies.
Many tick proteins, such as vitellogenin  receptor20, I. scapularis Bm86 orthologs, and ATAQ  proteins13, feature 
epidermal growth factor (EGF)-like domains, although their functions in vector biology remain elusive. The 
Bm86 antigens in particular feature multiple EGF-like  domains13. Proteins harboring EGF-like domains have 
demonstrated the evolution of multiple distinct  functions21. They are associated with stimulating cell growth and 
restoring membrane damage, in addition to supporting microbial virulence, such as the invasion of Plasmodium 
falciparum into  erythrocytes22 and Neisseria meningitidis23 into endothelial cells. Recent studies have shown that 
a monoclonal antibody against an EGF-like domain of a Plasmodium protein prevented parasite invasion via 
inhibition of the pathogen’s erythrocyte-binding  capacity24. In the fruit fly, the EGF receptor pathways control 
stem cell proliferation and gut remodeling following  infection25. While multiple proteins with EGF-like domains 
from hard and soft ticks were  identified20,26, their roles in vector physiology or development remain enigmatic. 
The tick gut presents a pivotal microbial entry point and serves as the major organ for pathogen colonization and 
survival within the vector, especially for the Lyme disease pathogen, as it resides exclusively in the tick  gut27,28. 
Here we report that Bm86 orthologs in I. scapularis (Is86) are expressed in the tick gut and contain three EGF-like 
domains, and that immunization with recombinant EGF-like domains influences optimal blood meal engorge-
ment and the molting of I. scapularis, in addition to partially blocking pathogen transmission from tick to host. 
These studies may help in the development of anti-tick vaccines to combat Lyme disease.
Results
Identification and expression of epidermal growth factor (EGF)‑like domains in I. scapula-
ris. As the Bm86 glycoprotein in cattle ticks has been used as a commercially available vaccine against tick 
infestation in  cattle17,29,30, we sought to know if vaccination with the Bm86 ortholog in I. scapularis exerts similar 
effects. Using the NCBI BLAST program to compare sequences with R. microplus Bm86 and I. ricinus orthologs 
(Ir86), we noticed that there were multiple Bm86 transcript variants in I. scapularis, as shown in sequence align-
ments (Fig. 1A). Using specific primers (Table S1) and the I. scapularis cDNA template, two homologs termed as 
Is86-1 and Is86-2 were PCR amplified. Furthermore, Bm86 features at least three identifiable epidermal growth 
factor (EGF)-like domains, designated herein as EGF-1, EGF-2, and EGF-3 (Fig. 1A). The sequence analysis 
indicates that EGF-3 is identical for both Is86 homologs, whereas EGF-1 and EGF-2 have sequence specificities 
for Is86-1 and Is86-2, respectively, with a sequence similarity of 47.9% between the two domains (Fig. S1A). 
Next, we generated the recombinant versions of the EGF-1, -2, and -3 proteins in a bacterial expression system 
(Fig. S1B, upper panel). Antisera were also raised in mice that specifically recognized the corresponding recom-
binant EGF proteins (Fig. S1B, lower panel). The phylogenetic tree analysis (Fig. 1B), comparing Is86 with Bm86 
orthologs from a representative set of other hard and soft tick species, demonstrated a clear orthology with Ir86 
of I. ricinus, which is the closest relative among the tested tick species, and showed protein homologies of 88% 
and 44% for Is86-1 and Is86-2, respectively. The Bm86 of R. microplus clustered with other Rhipicephalinae tick 
species, such as Dermacentor and Amblyomma. Interestingly, a putative Bm86 ortholog from the soft tick species 
O. savignyi was subgrouped with Is86-1.
Borrelia burgdorferi infection induces Is86 expression in ticks. To explore the biological function 
of Is86 in I. scapularis and its roles in B. burgdorferi infection, we first investigated the expression of Is86 in 
ticks with or without spirochete infection. Consistent with previous reports that the Bm86 gene was expressed 
specifically in the tick gut with upregulation during  feeding13, Is86 was expressed predominantly in the Ixodes 
tick gut and was completely absent in the salivary glands. Furthermore, although not statistically significant, the 
mean Is86 level in infected tick guts was 1.8-fold higher than in naïve ticks (Fig. 2A). We also assessed whether 
B. burgdorferi infection influences Is86 expression kinetics during the course of tick feeding. The results showed 
that Is86 expression was upregulated after the onset of tick feeding, with the level of expression steadily elevat-
ing and peaking at day three. Decreased expression was observed in post-fed ticks in a level comparable to that 
of unfed ticks (Fig. 2B), potentially because there is a reduced requirement for the protein following repletion, 
as it is possibly involved in the development and remodeling of the tick gut during feeding events. The level of 
Is86 in B. burgdorferi-infected tick guts was constantly higher compared to naïve ticks during feeding (Fig. 2B). 
Consistently, a specific reaction around 100 kDa was detected in tick gut proteins using the pooled Is86 EGF 
antisera, and the protein level in infected tick guts was higher than in naïve ticks (Fig. 2C, Fig.S6). In order to 
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support the specificity of the reaction, we isolated native Is86 from unfed adult tick guts using immunoprecipita-
tion (Fig. S3, left panel), which specifically reacted with EGF antisera at a molecular weight of about 100 kDa 
(Fig. S3, right panel). Similarly, immunofluorescent staining showed that a specific reaction was detected in both 
naïve and B. burgdorferi-infected tick guts (Fig. 2D). Although our study used permeabilized gut samples, the 
predominant distribution of immunofluorescent signals towards the luminal side of the Ixodes gut is consistent 
with the prevailing notion that Bm86 is expressed on the surface of the tick gut epithelial  cells13,31. Furthermore, 
an apparent higher fluorescence was observed in infected tick guts, as compared to naïve ticks (Fig. 2D). Taken 
together, these results indicate that B. burgdorferi infection could upregulate Is86 expression.
Next, we tested which Is86 homologs (Is86-1 or Is86-2) were expressed temporally in ticks at various stages 
of the life cycle. Since EGF-1 and EGF-2 are predominantly represented in Is86-1 and Is86-2, respectively, we 
used antiserum against each EGF domain. EGF-2 was detected in unfed nymphal ticks (Fig. 3A), while both 
Is86 homologs were detected in unfed (Fig. 3B) and partially fed (Fig. 3C) adult tick guts. Protein levels were 
upregulated after B. burgdorferi infection (Fig. 3A–C). The homologs displayed the same migrating patterns 
and sizes in both nymphal and adult ticks. In silico analysis revealed various patterns and types of posttransla-
tional modifications (Fig. S2). Interestingly, analysis of the unfed naïve larvae revealed the presence of both Is86 
Is86-1     1 -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Is86-2     1 --------------------------------------------------------------------------------------------------------------------------------------MKDLYENCQIKKEKEISCEEAQAIARIDQNGRV--YCDCGPAKTY--HNGKC-------------------------- 
Isca_X1    1 -----------MRSLCLFVWSAHFACCVIVTCSPQTGIMQARENQNHRFQGDDFKDICTEGSVGFKACHEMGAFCS-AIQAKKTFQCVCWREDLYYDANETMCKHWQSCEPNPCRYGKCTDQGGKTPRSCSCPRMKDLYENCQIKKKKELSCQEAEAIARIDQNGRV--YCDCGPAKTY--HNGKCELTGCLNYRKTCQDLCNENILDKDDR 
Isca_X2    1 -----------MRSLCLFVWSAHFACCVIVTCSPQTGIMQARENQNHRF-----QDICTEGSVGFKACHEMGAFCS-AIQAKKTFQCVCWREDLYYDANETMCKHWQSCEPNPCRYGKCTDQGGKTPRSCSCPRMKDLYENCQIKKKKELSCQEAEAIARIDQNGRV--YCDCGPAKTY--HNGKCELTGCLNYRKTCQDLCNENILDKDDR 
Isca_X3    1 -----------MRSLCLFVWSAHFACCVIVTCSPQTGIMQARENQNHRFQGDDFKDICTEGSVGFKACHEMGAFCS-AIQAKKTFQCVCWREDLYYDANETMCKHWQSCEPNPCRYGKCTDQGGKTPRSCSCPRMKDLYENCQIKKKKELSCQEAEAIARIDQNGRV--YCDCGPAKTY--HNGKCELTGCLNYRKTCQDLCNENILDKDDR 
Isca_X4    1 -----------MRSLCLFVWSAHFACCVIVTCSPQTGIMQARENQNHRFQGDDFKDICTEGSVGFKACHEMGAFCS-AIQAKKTFQCVCWREDLYYDANETMCKHWQSCEPNPCRYGKCTDQGGKTPRSCSCPRMKDLYENCQIKKKKELSCQEAEAIARIDQNGRV--YCDCGPAKTY--HNGKC-------------------------- 
Isca_BM    1 ------MRPLIVFALAVFAWTARTS--------PVLGLALQNEANEDQTIHEDPKGICK--RVGSSLCGDL-ATCV-ALPAKDSFQCSCPKG-GFYDANDKTCKHWQSCGPLPCKIGYCDDGNGSKKRHCKCGGIPGLTEFCKINKEAKFKCEEYGATAVL-KGDEV--TCDCGPAKKL--INKKCVPVACLNFTMTCEELCQKKLLDKDDR 
Isca_BM-L  1 ------MRPLIVFALAVFAWNARTS--------PVLGLALQNEANEDQTIHEDPKGICK--RVGSSLCGDH-AKCV-ALPAIDSFQCSCSKG-GFYDANDKTCKHWQSCGPLPCKIGYCDDGNGSKKRHCKCGGIPGLTEFCKINNDEKFKCEEYGATAVL-KGDEV--TCDCGPAKKL--INKKCVPVACLNFTMTCEELCQKKLLDKDDR 
Iric-1     1 ------MKPLLVFALAVFAWNARTS--------PVLGLALQNEANEDQAIHEDPKGICK--RVGSSICGDL-ATCV-ALPAIDSFQCSCRNG-EFYDANDKRCKHWQSCGPLPCKLGNCIDENGSKKRHCSCRAIPGLTEFCRINNDAKFKCEEYGATAVL-KGDKV--TCDCGPAKKL--INKKCVPVACLNFTMSCEELCQKKLLDKDDR 
Iric-2     1 ---------------------------VIVTCLQQTGNTRAREKQNHRFQDDDFKDICTEGRVGYEACHNMGAFCT-PIQAQKTFQCDCWREDLYYDANETMCKHWQSCEPNPCRYGKCNDQDGKKPRSCSCPGMKDLYGNCQINSEKKLSCERAEAKARIDPNGRV--YCDCGPAKTY--DNGKCELTGCLNYSKTCQELCNENILDKDDR 
R.mic      1 ------MRGIALFVAAVSLIVEGTA---------E-------------------SSICS--DFGNEFCRN--AECEVVPGAEDDFVCKCPRDNMYFNAAEKQCEYKDTCKTRECSYGRCVESNP-SKASCVCEASDDLTLQCKIKNDYATDCRNRGGTAKLRTDGFIGATCDCGEWGAMNMTTRNCVPTTCLRPDLTCKDLCEKNLLQRDSR 
D.ret      1 ------MRSLILLVAAISLIGGCAS---------K---D-IPHVAPQDPPALTPPPVCS--DFGNKFCDT--AKCEMVPGKTDAFVCRCERNDTYYDAAERTCLFKRTCKTTECTIGTCFETGI-NKARCGCPNMDYLTVNCQIRDFFIEDCKSKGGTAVLRKDWYSGAKCDCGEWAVMDSNKSKCVPTTCLRPDLTCKDLCENKLLEKDNR 
R.san      1 ------MRGIALFVAAVSLIGGCAA---------Q-------------------SSVCS--DFGNEFCGN--AVCEVVPGAEHDFVCKCPGDDMYYNAAEKHCEYKSTCKTKECSYGRCAQISP-RKAVCGCDGVDSLTQRCNIQGWYADECRRKGGTAKLRTDGFLGAKCDCGEWSVMDRNKRKCVPTTCLRPDLTCKDLCEKNLLEKDSR 
A.aur      1 ------MRHFIVFVAGALLIGKTSG---------D---E-TPT------QKPPPADICN--EFGNEFCKH--AKCSASLDVKGTFTCKCERDNMYFDAAKGMCQYKRSCATMECSVGECKEGNTHSQAKCVCENKDHVTLYCKVEDFFAKDCQRKGGTAMVNMKSMGGARCNCGKWAVMNSNKTKCVPTTCLYPALSCKDLCEKNLLDKDTR 
A.var      1 ------MRHFMVFVAGVLLIGNSAG---------D---E-AAP------QTVPPADVCS--DFGNDFCERP-ATCHASTDVKETFTCKCDRDDMYYDAVKEMCLYKKTCETVECSIGRCREPSI-NRAKCSCEDLESLTLHCNVKDYFIKHCEEKGATAVVDPQAYGGARCRCEEWTVMNSDKTKCVPTTCWYPSLSCKDLCEKKLLDKDQN 
O.sav      1 ------MRRLHVVLALL---------CVLRN-VTAAGTV---SDEQQGEVGRPSQDVC--GRVGNALCGSH--ACV-ALPNEGTFFCDCGQD-HFYDVRDATCAHVQSCTASRCQFGICSDEGRTVPATCDCTDISSLTPSCEVTQEKKEECSMIGAIPSVGPNSEV--DCLCRPGEVF--KNDRCLPTTCLNFSNTCEQLCKRRQLNEDHR 
R.mic_ATAQ 1 MGRMNNERSLFAVLFVVFLA--SLA-------------------TVAFAEEIPDMDICA---SAGKLCGTV--PCV-PINGSQYFTCLCENE-RYFNATAQRCYHLDSCSEILCLPGKCFDNHGSDAATCDCSGIHGMTKECEVDEAFRDECVKSGGEQTFDQNGFP--QCVCPYGTQL--ENDRCLSIACLLPDFTCADICNNPKLREDNR 
D.var_ATAQ 1 ------MNDVWPLLPLVLAA--NLS-------------------ATASADETP-DDICA---SAGQLCGIT--PCV-PLNDNKYFTCHCGDD-RYFNATAQRCYHLDACSAMLCHPGKCIDNDGNDVARCDCSGIHGMTEECQVDSAFRDECVKSGGEQSLDRDGRP--HCICPHGTEL--EDGTCKSIACLLPDFTCKDICNNAKLREDSR 
Is86-1     1  --MKDLYENCSKTPDETRYCKPGYISR--NDSCVDACTAKVADPLCPNGCKSSA-TDLPFQCICKKGFQLAEDGITCTE-----RRVCNEEEKKRCRKD-QICGIVND-EVTCSCKSHQQEKDGVCTNECFVKKCSDPFANCEVYLGTEKCFCTRPLFS----TRNITCGLE-KYSYILTFRTNDTSPY----SDDLCESKKEDIWKALKT 
Is86-2     49 ----------ERPPIASTFCPTGYVRL--RGQCRDACTANVTSPICPEGCTPMTNDQMPFHCKCKSGFELAEDGLTCRE-----KVVCNEEEKKKCHES-EICTIIDT-KAVCTCAEGLQRLNGVCTDKCTT-KCDHKFAKCVIIDRYERCTCIYPLSKTS--NGNQMCTLE-FYSYILVFQTNDTEPY----TSSFCDNKLPDITSALKV 
Isca_X1    197CCEGWNVSNCSRPPIASTFCPTGYVRL--RGQCRDACTANVTSPICPEGCTPMTNDQMPFHCKCKSGFELAEDGLTCRE-----KVVCNEEEKKKCHES-EICTIIDT-KAVCTCAEGLQRLNGVCTDKCTT-KCDHKFAKCVIIDRYERCTCIYPLSKTS--NGNQMCTLE-FYSYILVFQTNDTEPY----TSSFCDNKLPDITSALKV 
Isca_X2    192CCEGWNVSNCSRPPIASTFCPTGYVRL--RGQCRDACTANVTSPICPEGCTPMTNDQMPFHCKCKSGFELAEDGLTCRE-----KVVCNEEEKKKCHES-EICTIIDT-KAVCTCAEGLQRLNGVCTDKCTT-KCDHKFAKCVIIDRYERCTCIYPLSKTS--NGNQMCTLE-FYSYILVFQTNDTEPY----TSSFCDNKLPDITSALKV 
Isca_X3    197CCEGWNVSNCSRPPIASTFCPTGYVRL--RGQCRDACTANVTSPICPEGCTPMTNDQMPFHCKCKSGFELAEDGLTCRE-----KVVCNEEEKKKCHES-EICTIIDT-KAVCTCAEGLQRLNGVCTDKCTT-KCDHKFAKCVIIDRYERCTCIYPLSKTS--NGNQMCTLE-FYSYILVFQTNDTEPY----TSSFCDNKLPDITSALKV 
Isca_X4    171----------ERPPIASTFCPTGYVRL--RGQCRDACTANVTSPICPEGCTPMTNDQMPFHCKCKSGFELAEDGLTCRE-----KVVCNEEEKKKCHES-EICTIIDT-KAVCTCAEGLQRLNGVCTDKCTT-KCDHKFAKCVIIDRYERCTCIYPLSKTS--NGNQMCTLE-FYSYILVFQTNDTEPY----TSSFCDNKLPDITSALKV 
Isca_BM    189CCQGWNIENCSKTPDETRYCKPGYISR--NDSCVDACTAKVADPLCPNGCKSSA-TDLPFQCICKKGFQLAEDGITCTE-----RRVCNEEEKKRCRKD-QICGIVND-EVTCSCKSHQQEKDGVCSNECFVKKCSDPFANCEVYLGTEKCFCTRPLFP----TRNITCGLE-KYSYILTFRTNDTSPY----SDDLCESKKEDIWKALKT 
Isca_BM-L  189CCQGWNIENCSKTPDETRYCKPGYISR--NDSCVDACTAKVADPLCPNGCKSSA-TDLPFQCICKKGFQLAEDGITCTE-----RRVCNEEEKKRCRKD-QICGIVND-EVTCSCKSHQQEKDGVCSNECFVKKCSDPFANCEVYLGTEKCFCTRPLFP----TRNITCGLE-KYSYILTFRTNDTSPY----SDDLCESKKEDIWKALKT 
Iric-1     189CCQGWNVEDCSKTPDEKGYCKTGYISR--NNSCVDACTANVADPLCPDGCKSPA-TGRPFECKCKKGFQLAEDGLTCTE-----RRVCDKDEKKRCRED-QICGIVNA-EAKCSCKVHQQEKDGVCTDQCLVKECSSPFANCEVYLGMETCFCTPPLSS----IGNSKCGLG-KYSYILRFRTNDTSPY----SDDFCKSKEEDIRKALRT 
Iric-2     181CCEGWNVSNCSKPPIASTFCPTGYVRV--HGQCQDACTANLASPICPEGCTPTTNDQRPFHCKCKSGFELAEDGLTCRE-----KVVCNEEEKKKCHES-EICTILDT-KPVCTCAEGLQRLNGVCTDKCTT-KCDHKFAKCVIIGRYERCSCIYPLSKTS--KGDQMCTLE-FYSYILVFQTNDTEPY----TSSFCDKKLPDITSALKV 
R.mic      174CCQGWNTANCSAAPPADSYCSPGSPKG-PDGQCINACKTKEAGFVCKHGCRSTG---KAYECTCPSGSTVAEDGITCKSI--SHTVSCTAEQKQTCRPT-EDCRVHKG-TVLCECPWNQHLVGDTCISDCVDKKCHEEFMDCGVYMNRQSCYCPWKSRKPGPNVNINECLLN-EYYYTVSFTPNISFD------SDHCKWYEDRVLEAIRT 
D.ret      189CCQGWNSEDCSVVPQDGTYCSPGSIMV-KGGNCQDACTAKEAKFVCANGCRKTQSSTRAYECQCERDYVVAEDGITCKYSAVWMTNSCNEEEKKTCLSS-QTCYLEKN-KPICKCPHNHQLVNGECTSRCTENKCHEKFMDCGVYIDRQSCFCPWKSRKPGQ-VYNNECILR-EYYYTVSFTPNITLD------ANNCHLYTGLVVEAIKT 
R.san      174CCQGWNSANCSTAPEEGSYCSPGNLKG-KDGSCKDACSAKEGTLVCKYGCKGSTKPMRAYECECQSGDEVAEDGITCKRV--PYTGDCSDEQKKTCRPS-EYCLVRKG-KVVCECPMRQHLVNDECTSDCVDDKCHENFTECGVYMSKQNCYCPWRTRKPLPNVSINECVLN-EYYYTVSFTPNISLD------SRSCDSYAARVLDAIRT 
A.aur      184CCEGWDQKDCSKAPQDGTYCSPGTIR--KEGSCLSACTAGEAKLICKNGCRKARDSVRAYECVCNSGYVVAEDGIQCKVD--NRRDACSQEDEQTCLPG-QYCIMKNN-AAVCECPINQRLVKGKCTGGCSENKCHEDFGDCDIYFGRQSCFCPWTHRKHPKSPVTKVCRLN-EYYYTVTFRPNISLD------ARDCAVHETRVLQAMQT 
A.var      184CCEGWDQNDCSKAPEDGTYCSPGTIR--KDGSCQSVCQTGEAKLLCKNGCKRSQVPGRAFECRCNSGYVVAEDGIQCKVD--YTRLDCTQEDQQKCLPGGQNCIMRNK-TAVCQCPYNQHLLNGKCTDECSENDCHERFTDCDVYSGKQRCSCPWTLRKNRHSPATKECTLN-EYYYTVSFKPNISLD------AYHCDAHKARVLQAMRT 
O.sav      184CCQGWEHDICTAPEVEGGYCKPGYIKTTSHERCIDACSAGETNPVCPSGCTSNTTDGMPYNCVCGEDQELAHHGLGCIP-----KTGCSPEEKAKCRED-QECVLEEGHVAACKCPANQLERNGQCSGNCTR-ECQHTFASCRISDNQEQCQCSSPLEDASPTGRDGTCVLE-KYAYLTSFKLNRSLAS--WKVAYDCRQMKDSVMEAFSV 
R.mic_ATAQ 181CCQNWEIGSCDGNYEE-SFCPPGTTGN--GSICTNVCAEDLLGSVCEHGCTYENSSNPYYKCNCDDGEELSADGRTCQA-----RVECNEEEESSCEDSGQECVYKDG-KASCQCPAGSALIDGVCSEECSF-KCQPLLSKCVIDSNEEICVCEYPLKWDS---TKQQCTLDRQFVYIITFTQDQVYLTA--NTTHRCANTEKLIQSAMKN 
D.var_ATAQ 174CCQNWEAGSCDAHYEEGSFCLPGTIGN--GSVCTNVCAEDLLGPVCEHGCTYENSSTPDYKCKCEDKDEFAADGRTCQA-----RVECNEEEARSCEESGEICVIKDG-EASCECPLGYAMVGGICSKKCSL-KCQPSLSKCIIDSQMETCVCEYPLKWDH---AKQQCILDKQFLYTTTFEQYQSSITATTYTTRSCAKIGQLIDQAMRN 
Is86-1     191LFGAQLVDDTLLSCKEDFVIRLTFSQKQDPAVLKRIETCQY-LRGDVCIFPPRLYIKEGSAK-LEEEDLCTDFFQKQLNKSNGMYVCQKVG-DNYLFKCRDGLFSYNEVTSGRLTRWSCADKREDIPLASSESQK----------------------------------------------------------------LDPCISIPCFNN 
Is86-2     233VFGRELLKVETVSCKNEFVLRLVFENKQHPAVLRRMSNCQY-PQGDVCIFPPKLNVKATSLKAIKEEDLCAGILQELFNVSDASSECTKEE-DNYSIRCKEGFTAYGEVKSGRLTRWFCKAKDLLTSSSTESNAP------------------ETV--------------------------SPEAG--SRETTTLNNPEDPCISIPCFNN 
Isca_X1    391VFGRELLKVETVSCKNEFVLRLVFENKQHPAVLRRMSNCQY-PQGDVCIFPPKLNVKAASLKAIE-ENLCAGILQELFNVSDASSECTKEE-DNYTIRCREGFTAYGEVKSGRLTRWSCKAKDLLTSSSTESNPP------------------ETI--------------------------STEAG--SRETTTLNNPEDPCISIPCFNN 
Isca_X2    386VFGRELLKVETVSCKNEFVLRLVFENKQHPAVLRRMSNCQY-PQGDVCIFPPKLNVKAASLKAIE-ENLCAGILQELFNVSDASSECTKEE-DNYTIRCREGFTAYGEVKSGRLTRWSCKAKDLLTSSSTESNPP------------------ETI--------------------------STEAG--SRETTTLNNPEDPCISIPCFNN 
Isca_X3    391VFGRELLKVETVSCKNEFVLRLVFENKQHPAVLRRMSNCQY-PQGDVCIFPPKLNVKAASLKAIE-ENLCAGILQELFNVSDASSECTKEE-DNYTIRCREGFTAYGEVKSGRLTRWSCK----------ESNPP------------------ETI--------------------------STEAG--SRETTTLNNPEDPCISIPCFNN 
Isca_X4    355VFGRELLKVETVSCKNEFVLRLVFENKQHPAVLRRMSNCQY-PQGDVCIFPPKLNVKAASLKAIE-ENLCAGILQELFNVSDASSECTKEE-DNYTIRCREGFTAYGEVKSGRLTRWSCKAKDLLTSSSTESNPP------------------ETI--------------------------STEAG--SRETTTLNNPEDPCISIPCFNN 
Isca_BM    381LFGAQLVDDTLLSCKEDFVIRLTFSQKQDPAVLKRIETCQY-LRGDVCIFPPRLYIKEESAK-LEEEDLCTEFFQKQLNKSNGMYVCQKVG-DNYLFKCREGLFSYNEVTSGRLTRWSCADKREDIPLASSESPKL----V-----TDKEPQPGTE---GNVTK--------NTPVPDVTDKEPQTGTEGTVTKTTPVSDDPCSPSPCVNG 
Isca_BM-L  381LFGAQLVDDTLLSCK---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Iric-1     381LFGAQLVDDTFLSCEEDIVIRLTFSQKQDPAVLKRIETCQY-LRGDVCIFPPRLYIKEGSAK-LEEEDLCTEYFQEQLNKSKGMYVCQKVG-DNYLFKCRDGLFSYNKVTSGRLTHWSCADKREDIPPESSESPKS----V-----TDKEPQPGTE---GSGTK--------NTPVPDVTDKEPQPGTEGTGTKSTPVPDDPCSSSPCLNG 
Iric-2     375VFGRELLKVETVSCKKEFVLRLVFENKQHPAVFRRMSNCQY-PQGDVCIFPPKLNVKAASLKAIEEEDLCAGILHGLFNISDASSECTKEE-DNYTIRCKEGFTAYDEVKSGRLTRWSCKAKDLLTSSSTESIPP------------------GTV--------------------------STQAG--SRETTTSTNLEDPCISIPCFNN 
R.mic      370SIGKEVFKVEILNCTQDIKARLIAEKPLSKHVLRKLQACEH-PIGEWCMMYPKLLIKKNSATEIEEENLCDSLLKDQEAAYKGQNKCVKVD-NLFWFQCADGYTTTYEMTRGRLRRSVCKAGVSCNENEQSECADKGQIFVYENGKANCQCPPDTK--------------------------PGEIGCIER--TT----CNPKEIQECQDK 
D.ret      389SIGKEVFMVEILNCTQKIKARLISANPLSKYLLKRLQTCEH-PDGDLCMLYPKLPIKKDTATEIEEEDLCDSLLKTQEEAYNGQNECVKVE-NFFWFKCAAGFRAVDYVTRGRLRRSICEPGVSCTPRKELECSKKGQICVYENKESKCQCLPGTV--------------------------AGQDGCSAEVPDS----CNEEESNECRSN 
R.san      373SIGNDVFKVEILNCTHDIKARLIASKPLSKHVIKRLQACEH-PVDDLCMLYPKLPIKKGSATEIEEENLCDSILKTQENGYKGQNKCVKVD-NFFWFQCADGYRAVDEITRGRLRRSVCEAGVSCSAKEQLECANKGQICVYENEKANCQCPPGTV--------------------------AGQAGCTAR--TT----CNPKEIRECQDH 
A.aur      382AIGPEIFKVEILSCTDHVKARLIAGKPLSHYLLRKLQTCEY-PEGNTCIIYPKLPILKGSATEIEEENLCDSLLKAQSGATKDTNECVIDG-DYFWFKCKPGFFQVDLKTSGRLRRSVCEPQAMCAEDK---------------------------------------------------------------------------NQECNNK 
A.var      383TIGPEVFMVEILSCTDDFKTRLITNNPLSPYLLKKLQTCEH-AEGDACIIYPKLPIQKGSATEIVEEDLCDSLLKPQADATKDTNDCVRDG-NYFWFKCKPGLREVDLKTRGRLRRSVCKPGVSCDVKDEQECHKTGHICTLEGQQAVCKCPLGKI--------------------------EDQGKCKA----T----CTQEKQDECKKN 
O.sav      385LFGSQFLTLDIISCKELYRIRLIFSEKQDQAVLNRLHLCKNSMKPETCYFWPDIHVVSGSVGPVAAENICETVLREPIEKYEGGYVCKVQD-DEIHFNCVNPAAVSGTETSGRITKQRCSEENKLPGKGENKGRE-----D-----EDQMPPSQTAVIVGAILAILAALGIIAIIVVSRKRKAAKAGQ----------------------- 
R.mic_ATAQ 377LYGKSLMATRLLKCGEEHEVELSFSEEPAPALLHRIHLCENEDKRSGCFFAPALYIVNGSSSDPRAVDLCDAYLNNTDAVSSGSHKCVSEGAGNYTLRCALRSAGAEMVQQGFLKVQRCHE--------------------------------------------------------------------------------GCHPNLCPQD 
D.var_ATAQ 373LYGENLMATRLLKCGEEHEVELSFSEEPAPALLNRIHLCENWDKTSGCFFPPALYIVNGTSSDPQAVDLCDAYLNSTAAVSSGSHMCVSEGAGTYLLQCALG-RGAAIIQQGSLKVQQCDE--------------------------------------------------------------------------------GCRPNPCPQD 
Is86-1     335GLCKKGPKNTYVCECKQGFS--------------------------GERCERN------------------------------AGKKLE----APLVVDIKFSIGMQLPLRGLFGFA------------------------- 
Is86-2     396GLCKKGPKNTYMCECKQGFA--------------------------GERCERN------------------------------AGKKLE----AQVVAVITFLIGMQLSLRWMFGLA------------------------- 
Isca_X1    553GLCKKGPKNTYVCECKQGFS--------------------------GERCERN------------------------------AGKKLE----APLVVVITFSIGMQLSLRWLFGFA------------------------- 
Isca_X2    548GLCKKGPKNTYVCECKQGFS--------------------------GERCERN------------------------------AGKKLE----APLVVVITFSIGMQLSLRWLFGFA------------------------- 
Isca_X3    543GLCKKGPKNTYVCECKQGFS--------------------------GERCERN------------------------------AGKKLE----APLVVVITFSIGMQLSLRWLFGFA------------------------- 
Isca_X4    517GLCKKGPKNTYVCECKQGFS--------------------------GERCERN------------------------------AGKKLE----APLVVVITFSIGMQLSLRWLFGFA------------------------- 
Isca_BM    569GVCKPGTEKTFTCECPKGFK--------------------------GNLCEEKN-----------------------------SGVSVQ----APVTAILGIAMSLLLLL-------------------------------- 
Isca_BM-L  381---------------------------------------------------------------------------------------------------------------------------------------------- 
Iric-1     569GVCKPGTGKIFTCECPKGFK--------------------------GNLCEEKN-----------------------------SGVSVQ----APVTTILGIAISLLLLR-------------------------------- 
Iric-2     538GHCKKGPNNTYLCECKKGFS--------------------------GERCERS------------------------------AGRKLE----AQVVAVITFSIAMQLSLRWMYGLA------------------------- 
R.mic      547KLECVYKNHKAECECPDD-----HECYREPAKDSCSEEDNGKCQSSGQRCVIENGKAVCKEKSEATTAATTTTKAKDKDPDPGKSSAAAVS-ATGLLLLLAATS--------V-TAASL----------------------- 
D.ret      568GQRCVLENQKAVCKEASNTP---APKEVDPAPSQCSEEVRKKCTEKGAECVTADGKAVCKCPEGKVETS-------QGCSDPGPSSAVTVS--STTLLLLAAMTAA--------AAA------------------------- 
R.san      550KRKCVYKDQKAECKCPEGTIDDGDGCSIEPAKEPCSEYEVGKCRSKGQSCVTENGKPVCKEISDATTAAAATTKAKDKDQEPCSEEDSGTCRSSGQRCVMEYGKPVCKKISDATTAATTT-----TKAKDKDQDRGKSSA-- 
A.aur      516GEDCVVENGEAVCKQKGDSS---ATTEASPAPATCTEEKNQECNNKGEECVVENDEAVCKKKGDSTATTQA---------PHGSGSRT-VP--VSVVLILAIMIPALYT--------------------------------- 
A.var      558GGECVIDKDEAVCTNKEDST---ATTEAPQVPATCTEERKAQCEKKGEECIVENAQAVCKAKVDSA-TTTA---------PPGSGSRI-VP--VSAVLLLAILIPALYT--------------------------------- 
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Figure 1.  Multiple sequence alignment and phylogeny of Bm86 orthologs. (A) Alignment of orthologous Bm86 
protein sequences in hard and soft ticks generated in Clustal Omega and BoxShade (https ://www.ch.embne 
t.org/softw are/BOX_form.html). The letters with a black background are identical amino acids, while gray 
background letters are similar under the 50% majority rule. Red arrows span the amino acid sequences that 
were used to generate the recombinant EGF-like domains 1, 2, and 3, as denoted by the red boxes. EGF-1 and 
EGF-2 are Is86-1 and Is86-2 sequence-specific, respectively, while EGF-3 is sequentially identical for both Is86-1 
and Is86-2. (B) Phylogenetic relationship of Bm86 orthologs among hard and soft ticks based on maximum 
likelihood tree. The numbers by the nodes represent a percent support using 1000 bootstrap replicates. A single 
asterisk indicates the putative sequences of Is86 recently added to the NCBI GenBank database, two asterisks 
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homologs migrating with the predicted molecular masses of 44.2 kDa (Is86-1) and 50.5 kDa (Is86-2) (Fig. 3D), 
suggesting an absence of posttranslational modifications of the protein homologs in larvae prior to blood meal 
engorgement. The testing of Is86 homolog expression in fully replete naïve and infected larvae failed, likely due 
to the blood content in the tested samples or the lack of protein expression (data not shown). Additionally, we 
did not detect any specific reactions in any stage of ticks using EGF-3 antiserum, suggesting that either the level 
of EGF-3 is low, or that the antigen does not contain an immunogenic epitope that could be recognized by the 
specific antiserum (Fig. 3, Fig. S7).
EGF‑like domain antibodies marginally interfere with tick physiology and affect B. burgdor-
feri transmission by ticks. Previous studies have shown that specific antibodies against Bm86 affect tick 
feeding on  cattle17,32. Despite promising activity as anti-tick vaccines, vaccination with the Bm86 orthologs in I. 






















































































Figure 2.  Expression and localization of Is86 in I. scapularis ticks. (A) Gene expression of Is86 in ticks. The 
naïve and B. burgdorferi-infected nymphal ticks were collected during feeding (at days 1, 2, and 3 of feeding, 
and when fully replete). The tick guts and salivary glands of unfed and fed ticks were dissected and pooled 
together according to tissue type. Is86 gene expression was measured by using qPCR and normalizing against 
the tick house-keeping gene rps4. (B) Kinetic Is86 expression over the course of tick feeding. Naïve and B. 
burgdorferi-infected ticks were collected at the indicated time points during feeding. Is86 gene expression was 
measured by using qPCR and normalizing against tick rps4. The results are presented as the median ± SEM from 
two independent experiments. (C) Is86 protein expression is induced in B. burgdorferi-infected tick guts. The 
proteins from naïve and B. burgdorferi-infected nymphs (pooled unfed and two-day fed guts) were either stained 
with Ponceau S to show an equal protein loading (upper panel) or probed with pooled antisera against Is86 EGF 
domains (lower panel). The arrowhead indicates Is86 immunoreactivity, which is notably induced in spirochete-
infected guts, in comparison to naïve tick guts. For an image of the full-length immunoblot, please refer to 
Fig.S6. (D) Is86 is localized towards the luminal surface of the unfed tick gut. Unfed tick guts were stained with 
anti-EGF (green) or normal mice serum (NMS), and the nuclei were stained with DAPI (blue) and visualized 
under the confocal microscope. The representative images are composites of Z-stack.
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nization with the whole protein, which may induce immunodominant but non-neutralizing antibodies, identify-
ing and focusing on the most conserved region of Is86 may produce the most useful and effective neutralizing 
antibodies. We sought to know whether EGF-like domain-specific antibodies targeting the Is86 homologs could 
impair tick physiology and consequently B. burgdorferi persistence and transmission by ticks. Groups of mice 
were immunized with individual Is86 EGF-1, -2, or -3, which elicited high titers of antibodies against the Is86 
homologs, in contrast to the controls (Fig. S4A). The mice were then infested with infected nymphs (10 ticks/
mouse), and feeding parameters were observed. Compared to the controls, significantly less fully replete ticks 
were collected from mice immunized with Is86 EGF-1 (Fig. 4A, p < 0.01), and the engorgement weights of the 
ticks were substantially lower (Fig.  4B, p < 0.01). Such data were not observed after immunization with Is86 
EGF-2 or -3, suggesting that antibodies against Is86 EGF-1 could interfere with tick physiology and result in 
a delay of tick feeding. Additionally, several unattached live and/or dead ticks were observed after feeding on 
mice in the experimental groups, which did not occur in the controls (Fig. 4B). The collected ticks were then 
stored in the incubator and allowed to molt. The percentage of molted ticks that had fed on mice immunized 
with EGF-2 was significantly decreased, with a molting rate of 40 ± 8.5%, as compared to the controls (81 ± 9.5%) 
(Fig. 4C, p < 0.05). As Bm86-based vaccines have been reported to partially block the transmission of tick-borne 
pathogens like B. ovis17, we also assessed the effects of EGF antibodies on Borrelia transmission by ticks. Ten days 
after tick feeding, murine skin samples were collected. The spirochete burden in mice immunized with EGF-1 
was significantly decreased compared to the controls (Fig. 4D, p < 0.05). This was not caused by disparities in 
spirochete burdens within the ticks (Fig. 4E), indicating that antibodies against the Is86 homologs do not impact 
the majority of spirochetes that persist in ticks, but potentially influence the dissemination of a fraction of B. 
burgdorferi through ticks.
We then assessed whether antibodies against the EGF domains interfere with spirochete acquisition by ticks. 
Mice were immunized with individual EGF-1, -2, or -3 (Fig. S4B), and then infected with B. burgdorferi via 
needle inoculation. Twelve days after inoculation, naïve ticks were allowed to feed on the mice. There were no 
significant differences in tick feeding duration (Fig. 5A) and tick engorgement weights (Fig. 5B) among the 
experimental and control groups. Although not statistically significant, there was an apparent effect on molting 
success, as the mean percentage of adult ticks that molted from engorged nymphs was reduced after feeding 
on EGF-2 immunized mice (50 ± 26%), as compared to control ticks (83 ± 17%) (Fig. 5C). Notably, after 48 h of 
feeding, the spirochete level in ticks that parasitized EGF-1 immunized mice was 44-fold lower (Fig. 5D, p < 0.01), 
and 4.7-fold and 8.3-fold lower in the EGF-2 and EGF-3 groups, respectively (Fig. 5D), in comparison to the 
controls. However, in fully replete ticks, only those that fed on EGF-3 immunized mice displayed a significant 
decrease in spirochete burden, when compared to control ticks (median of 11.6-fold, p < 0.05) (Fig. 5E). The 
impairment of spirochete survival in fed ticks was likely due to the neutralizing effects of anti-EGF antibodies 
in the ticks, but not in the murine hosts, as similar levels of B. burgdorferi were detected in the mouse dermis, 








































































































































Figure 3.  Expression of Is86 homologs in various tick stages. Nymphs were allowed to feed on naïve or infected 
mice and collected after 48 h of feeding. The naïve and infected adult ticks fed on an artificial feeding system and 
were collected after 48 h of feeding. The unfed nymphal ticks (A), as well as the dissected guts from (B) unfed 
adult ticks, (C) partially-fed (two-day) adult ticks, and (D) unfed larval ticks, were processed using SDS-PAGE, 
transferred to nitrocellulose membrane, stained with Ponceau S to show an equal protein loading (upper panel), 
and probed with antiserum against each Is86 EGF domain (EGF-1, -2, or -3). PBS and adjuvant-immunized 
sera were used as controls (CTRL). Arrows indicate the specific antibody response to Is86-1, and arrowheads 
indicate the specific response to Is86-2. For an image of the full-length immunoblot, please refer to Fig. S7.
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(Fig. 4E), B. burgdorferi transmission from tick to host was not affected, and comparable levels of spirochetes were 
detected in the mouse skin among all groups (Fig. 5F). As naïve and B. burgdorferi-infected ticks represent two 
different environments physiologically, where the expression of Is86 (Fig. 2) and EGF immunoreactivity (Fig. 3, 
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Figure 4.  Immunization with EGF domains affects tick feeding and interferes with tick transmission of B. 
burgdorferi. B. burgdorferi-infected ticks were allowed to feed on mice immunized with Is86 EGF-1, -2, or -3. 
Ticks that fed on mice immunized with adjuvant only were used as controls. The parameters of tick feeding 
were recorded. (A) Mean number of replete ticks, with error bars showing standard error of mean (± SEM). 
Fully replete ticks were collected and counted (n = 30, 24, 29, 27/group, respectively). The amount of EGF-1 ticks 
collected on day 4 was significantly lower (**p < 0.01). (B) Median tick engorgement weight, with error bars 
showing 95% confidence intervals (CI). The weights of individual fully replete ticks (n = 30, 27, 30, 30/group, 
respectively) were measured. Data points with zero values indicate unattached live or dead ticks collected 24 h 
post infestation. Fully replete EGF-1 ticks weighed significantly less (**p < 0.01). (C) Mean tick molting rate, 
with error bars showing ± SEM. The collected ticks were allowed to molt (n = 21, 15, 20, 17/group, respectively) 
in the incubator, and the percentage of molted ticks was calculated. The asterisks indicate statistically 
significant differences at p < 0.05. (D) Mean B. burgdorferi burden in mouse skin. This experiment represents 
the transmission of spirochetes from infected ticks to naïve mice. Murine skin samples were collected 10 days 
after tick feeding. Spirochete levels were evaluated by measuring copies of flaB using qPCR and normalizing 
against mouse β-actin. The B. burgdorferi burden was significantly reduced in mice immunized with EGF-1, as 
compared to controls (*p < 0.05). Bars represent the mean ± SEM of four qPCR analyses of B. burgdorferi levels 
from two independent animal experiments. (E) Median spirochete burden in ticks (n = 3/group), with error bars 
showing 95% CI. Spirochete burdens in fully replete ticks were assessed by measuring copies of flaB using qPCR 
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of anti-rEGF antibodies on the physiology of ticks without B. burgdorferi infection. In contrast to infected ticks, 
rEGF immunization did not significantly impact the feeding or molting parameters of naïve ticks (Fig. S5), likely 
due to the dramatically reduced production of Is86 antigens in naïve ticks (Fig. 3, Fig. S6).
Is86 silencing failed to interfere with B. burgdorferi persistence and transmission. To directly 
assess the role of Is86 proteins in tick physiology and B. burgdorferi infectivity, we employed an RNA interfer-
ence-mediated knockdown of Is86 in ticks. To efficiently knock down gene expression, two dsRNA constructs 
targeting different regions of Is86-1 and Is86-2 were generated (Fig. 6A). B. burgdorferi-infected nymphs were 
microinjected with the pooled dsIs86 RNAs, targeting both Is86 homologs, and allowed to feed on naïve mice. 
Compared to ticks injected with dsGFP RNA, Is86 transcripts in fully replete ticks were significantly decreased 
after treatment with dsIs86 RNAs (Fig. 6B). However, the silencing of Is86 did not affect B. burgdorferi persis-
tence in ticks (Fig. 6C). Ten days after tick feeding, mouse skin samples were collected. Comparable spirochete 
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Figure 5.  EGF immunization affects B. burgdorferi acquisition. Mice were immunized with Is86 EGF-1, -2, 
or -3, infected with B. burgdorferi, and then parasitized by naïve ticks. Ticks that fed on mice immunized with 
adjuvant only were used as controls. (A) Mean number of replete ticks, with error bars showing ± SEM. Fully 
replete ticks were collected and counted (n = 20, 17, 20, 16 ticks/group of 2 mice, respectively). (B) Median 
tick engorgement weight. The weights of fully replete ticks (n = 20, 18, 19, 17 ticks/group, respectively) were 
measured with error bars showing 95% confidence intervals (CI). Data points with zero values indicate 
unattached live or dead ticks collected 24 h post infestation. (C) Mean tick molting rate, with error bars 
showing ± SEM. The collected ticks were allowed to molt (n = 6, 7, 8, 7 ticks/group of 2 mice, respectively) in 
the incubator, and the percentage of molted ticks was calculated. Median B. burgdorferi burdens in (D) 48-h fed 
ticks and (E) fully replete ticks (n = 8, 7 ticks/group, respectively), with error bars showing 95% CI. Spirochete 
burdens in ticks were assessed by measuring copies of flaB using qPCR and normalizing against tick β-actin. (F) 
Mean B. burgdorferi burden in mouse skin (n = 2), with error bars showing ± SEM. This experiment represents 
the acquisition of spirochetes from infected mice to naïve ticks. Murine skin samples were collected after 
the completion of tick feeding. Spirochete levels were evaluated by measuring copies of flaB using qPCR and 
normalizing against mouse β-actin. The right-side panel shows a Western blot of B. burgdorferi lysates, which 
were probed with B. burgdorferi-infected mouse sera (control groups in lanes 1 and 2, EGF-1-immunized in 
lanes 3 and 4, EGF-2-immunized in lanes 5 and 6, EGF-3-immunized in lanes 7 and 8, and normal mouse 
serum in lane 9). The asterisks in the graphs indicate statistically significant differences at p < 0.05.
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(Fig. 6D). The results indicated that the RNAi-mediated knockdown of Is86 failed to influence spirochete persis-
tence in ticks and pathogen transmission to the host.
Discussion
Many tick proteins, including ones from I. scapularis, feature one or multiple EGF-like domains, although their 
functions in vector biology or pathogen persistence remain elusive. The Bm86 glycoprotein, originally isolated 
from R. microplus  ticks10,33,34, represents the only tick antigen to be commercially developed as an anti-tick vac-
cine, protecting immunized cattle from tick infestation. The vaccine is also partially effective in blocking the 
transmission of certain tick-borne pathogens, such as Babesia  parasites17,35. Although this study lacks concep-
tual innovation, as Bm86 orthologs have been subjected to many earlier studies, including the vaccination of 
Ixodes  species13 with Bm86 homologs, which failed to influence I. ricinus feeding or  oviposition18, our current 
study identified a biological significance of the EGF domains in Ixodes ticks. Particularly, we discovered that 
immunization with specific EGF-like domains in the Bm86 orthologs of I. scapularis (originally identified by 
Nijhof and  colleagues13,) could impact, at least to a marginal extent, tick feeding and molting success, as well 
as the survival of B. burgdorferi in the vector, highlighting their roles in tick biology and suggesting their use as 
potential components of anti-tick vaccines.
Based on the available I. scapularis genome  data36,37, we identified at least two homologs of Bm86 (Is86-1 and 
Is86-2); however, according to further updates in the NCBI database, these homologs likely incorporate additional 
members, including several splice variants. Nonetheless, our sequence alignment and phylogenetic analysis 
revealed that Is86-1 and Is86-2 represent prototypes of two major groups of Bm86 orthologs in black-legged 
ticks, which is in agreement with a previous  report13 that showed a divergence between these Is86 homologs from 
prostriata ticks to other hard tick species in the metastriata group. Notably, the relatively low sequence identity of 
Is86 homologs when aligned to the closely related I. ricinus Ir86 further underscores its extensive sequence diver-
sification, even across closely related tick species. Such sequence variability, which is also observed for Bm86 in 






















































































































Figure 6.  Silencing of Is86 fails to interfere with B. burgdorferi persistence in ticks and spirochete transmission. 
(A) Schematic representation of the full open reading frame of Is86-1 and Is86-2, showing regions targeted for 
RNA interference. The regions encompassing dsRNA constructs (red arrows) and detection primers that contain 
common sequences in both Is86-1 and Is86-2 (green) are shown. (B) RNAi induced a significant knockdown 
of Is86 transcripts (****p < 0.0001). The levels of Is86 gene transcripts in ticks that had been microinjected with 
pooled dsRNAs targeting Is86-1 and Is86-2 were significantly decreased compared to the dsGFP RNA control. 
(C) Silencing of Is86 did not affect spirochete persistence in ticks. Spirochete burdens in fully replete ticks were 
assessed using qPCR and normalizing against tick β-actin. (D) Silencing of Is86 did not block B. burgdorferi 
transmission from ticks. Spirochete burdens in murine skin were assessed using qPCR. The bars represent the 
mean ± SEM of four qPCR analyses of B. burgdorferi levels, derived from two independent animal experiments.
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the exact function of the Bm86 protein family still remains highly enigmatic, these gene-products feature several 
conserved domains that are typically found in the epidermal growth factor (EGF) family of  proteins13,15. The 
EGF domains are usually represented as a small domain of 30–40 amino acids which regulate a diverse array of 
cellular functions, primarily supporting the growth and development of an  organism14,21. In our present study, 
we identified at least three EGF-like domains in Is86 homologs in I. scapularis, although additional EGF domains 
have been reported to occur in various Ixodes spp.  ticks13.
An important role of Bm86 in the physiology of R. microplus ticks, as well as in the transmission of Babe-
sia species in cattle, was previously  reported17. In fact, vaccines based on Bm86 antigens have proven to be a 
feasible control method against R. microplus tick infestations in multiple countries. However, primarily due to 
the extensive sequence diversity across tick species, Bm86 orthologs are likely to undergo dramatic functional 
divergence, thereby lacking broad vaccine efficacy in many other tick  species32. In fact, an amino acid sequence 
divergence of greater than 2.8% could result in a decreased vaccine efficiency of Bm86  antigens39. Accordingly, 
as with I. ricinus ticks, vaccination with Bm86 homologs failed to influence tick feeding or  oviposition18. These 
findings agree with the results of our RNAi-mediated gene silencing studies, as the knockdown of Is86 homologs 
did not impact I. scapularis physiology or pathogen survival. The silencing of the R. microplus Bm86 gene via 
RNAi also failed to affect the efficiency of the transovarial transmission of B. bovis40. Nevertheless, despite an 
absence of gene silencing effects, the partial impact of immunization with the truncated Is86 antigens suggests 
the potential roles of the EGF-like domains in tick biology. The importance of these domains in Is86 (or similar 
antigens) in regards to tick biology is particularly highlighted by: (1) their induction during the tick engorge-
ment process, and more importantly during the B. burgdorferi infection of ticks, (2) their extracellular exposure, 
in particular towards the luminal surfaces of the midgut cells, and consequent antibody accessibility, (3) their 
copious expression throughout the tick developmental stages, including sub-adult and adult, (4) the abilities of 
anti-EGF antisera to impact, at least marginally, multiple aspects of tick biology, including blood meal engorge-
ment and molting, and finally (5) their detectable influences on spirochete survival in ticks, in terms of both 
pathogen acquisition and transmission through the vector to the host. In order to expand upon these promising 
initial results, the effect of EGF immunization on Borrelia transmission requires more elaborate studies to bet-
ter address the vaccine potential of these antigens. As Bm86 orthologs bear considerable sequence homology 
to closely related ticks, such as I. ricinus, similar studies would shed light on the potential applicability of EGF 
domains as global vaccines.
Despite our identification of the EGF-like domains in Is86 antigens as a possible component of anti-tick vac-
cine targets, we were unable to decipher their precise biological functions. Vaccination against its ortholog, Bm86, 
reportedly resulted in tissue damage in the midgut of adult B. microplus  ticks41. Based on our data, no such effect 
was apparent in I. scapularis nymphal ticks, either via anti-Is86 immunization or through RNAi-mediated gene 
silencing. It is therefore possible that the anti-Is86 antibodies are cross-reactive to other unknown tick proteins, 
and that the observed vaccination effects of EGF-like domain antibodies are impacted by their recognition of 
other cross-reactive antigens, rather than the specific inhibition of Is86 homologs. Although our immunoblot 
and immunoprecipitation studies using anti-EGF antibodies failed to identify additional tick proteins other than 
Is86, these antibodies still can bind to and inhibit the activity of unidentified tick gut proteins through steric 
 hindrance42, which could play essential supportive roles in tick biology and pathogen survival.
We noticed perplexing discrepancies in the abilities of specific EGF antisera to detect target proteins at vari-
ous tick feeding or developmental stages. Although Bm86 orthologs are known to be glycosylated, our study 
recorded a puzzling and substantially higher molecular weight of both Is86 orthologs. Some tick physiological 
parameters were affected to some extent for both homologs, but more significant results were observed with 
anti-EGF-1 antibodies (Is86-1). While the expression patterns of the homologs were comparable towards the end 
of tick feeding, differences were noted in unfed and early-fed ticks, with Is86-1 being absent in unfed tick guts 
and generally being expressed at lower levels than Is86-2. It is also possible that, in addition to or in lieu of Is86, 
the EGF antibodies also detected multiple patterns of Is86 glycosylation, splice variants, or cleavage products, 
or recognized additional cross-reactive tick antigens, that are differentially produced during tick feeding or the 
development process. Nevertheless, we observed that Is86-1 contained a broader spectrum of posttranslational 
modifications at a higher frequency than Is86-2. Such differences may be a contributing factor as to why the 
antibody-based blocking of Is86-1 caused physiological changes in ticks, such as delayed feeding and reduced 
weight, indicating a dominant physiological function of Is86-1. Although marginal, as EGF-1 and EGF-2 antibod-
ies affected distinct phases of tick biology, namely blood meal engorgement and the molting process, respectively, 
it is likely that both Is86 homologs, or other tick gut protein(s) with cross-reactive EGF antibodies, have pre-
dominant functions at distinct phases of the tick life cycle. Our study also uncovered a novel mode of action for 
the EGF-based antigens, suggesting that other unknown molecules are implicated in the process. This may also 
include tick molecules that are induced during borrelial infection, and/or the spirochete proteins that interact 
with the gut surface receptors and the antibodies targeting EGF-like domains, which interrupt that interaction.
There has been an increasing body of evidence that EGF-like domains are involved in versatile functions 
during cellular growth and  development21, including protein–protein  interactions43 and cellular adhesion with 
concomitant intracellular  signaling44. In particular, due to the well-documented roles of EGF proteins in cell 
growth, proliferation, repair, or remodeling, as well as infection  control22,23,25, it is likely that the EGF domains 
in Is86 proteins may serve critical roles in Ixodes biology and infection. We speculate that the induction of Is86 
during blood meal engorgement, or more notably during infection, could involve discrete protein–protein inter-
actions relevant to B. burgdorferi, either directly via EGF domain interactions with spirochetes, or indirectly via 
another EGF domain-containing protein. This possibility is bolstered by the fact that EGF-like domains in Is86, 
or in other cross-reactive proteins, are exposed predominantly at the luminal side of the tick gut epithelium (a 
localization pattern also reported for  Bm8614), where extracellular pathogens like B. burgdorferi reside and express 
a plethora of surface antigens, many of which are known to be involved in host–pathogen  interactions27,45. A 
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deeper understanding of the biological functions of the Is86 homologs and their roles in I. scapularis tick physiol-
ogy, as well as the precise molecular mechanisms through which antibodies against EGF-like domains or other 
novel tick antigens of unknown functions reduce spirochete entry and exit through ticks, will not only enrich 
our knowledge of tick-pathogen interactions, but will also ultimately impact the development of new strategies 
for the prevention of tick-transmitted infections.
Methods
Bacteria, mice, and ticks. Borrelia burgdorferi  sensu stricto infectious isolate B31 A3, grown in Bar-
bour-Stoenner-Kelly-H (BSK-H) medium, was used throughout this  study46. Four- to six-week-old C3H/HeN 
mice were purchased from the Charles River Laboratories. All experimental protocols were approved and per-
formed in accordance with the guidelines of the Institutional Animal Care and Use Committee and Institutional 
Biosafety Committee of the University of Maryland, College Park. The study was carried out in compliance with 
the ARRIVE guidelines. Ixodes scapularis tick egg masses were purchased from the Oklahoma State University 
Tick Rearing Facility. Larval ticks were allowed to feed on naïve or B. burgdorferi-infected  mice47; upon engorge-
ment, the ticks were collected and maintained in an incubator at 20 °C with 95% relative humidity and a 12-h 
light/dark photoperiod regimen. The collected larvae were allowed to molt to nymphs, which typically took 
4 weeks. The unfed nymphs were then allowed to parasitize mice; when fully replete, the ticks were collected and 
allowed to molt to adult ticks in the incubator.
Polymerase chain reaction (PCR). The oligonucleotide sequences for each of the primers used in specific 
PCR reactions are listed in Supplementary Table S1. The pathogen-free naïve and B. burgdorferi-infected unfed 
and fed nymphal ticks were collected at various time points during feeding (Days 1, 2, or 3, or as fully replete 
ticks). The tick specimens were immobilized, and the midgut and salivary glands were dissected. To increase 
the sensitivity of Is86 detection in our initial experiments, we pooled tick samples from various time points of 
feeding and used a generic qPCR primer pair that could detect other Is86 transcripts. Additionally, groups of 
naïve or B. burgdorferi-infected mice were parasitized by naïve or infected ticks, which were allowed to feed to 
full repletion, and murine skin biopsies were collected ten days after the ticks dropped off. Due to challenges 
associated with their size, larval and nymphal samples were processed differently. Nymphs were dissected for 
the isolation of specific organs (such as the gut or salivary glands), whereas larval samples were processed as 
entire bodies. Total RNAs were isolated either from tick or mouse tissues using TRIzol (Invitrogen), reverse 
transcribed to complementary DNA (cDNA) (Invitrogen), and treated with DNase (NEB) to minimize DNA 
contamination as  detailed48.The gene transcripts were analyzed using quantitative PCR (qPCR). The amplifica-
tion parameters for rps4/Is86 are as follows: initial denaturation at 95 °C for 5 min, followed by 40 cycles each at 
95 °C for 10 s, 55 °C for 20 s, and 72 °C for 30 s. The amplification parameters for tick β-actin/flaB are as follows: 
initial denaturation at 95 °C for 5 min, followed by 40 cycles each at 95 °C for 10 s and 60 °C for 1 min. The final 
step in both amplification cycles was the melt curve analysis at 55 °C for 30 s, increased by 0.5 °C per cycle to 
95 °C. The amplification was performed in an iQ5 real-time thermal cycler (Bio-Rad) using SYBR Green Master 
Mix (Thermo Fisher Scientific). The relative transcript levels of Is86 were measured against the tick house-
keeping gene rps4 in a three-step amplification cycle using annealing temperatures of 55 °C as  detailed49. The 
relative spirochete burdens were assessed by measuring copies of flaB transcripts as a better surrogate for live 
 pathogens48 in a two-step amplification cycle, using annealing temperatures of 60 °C and normalizing against 
the β-actin gene as  detailed48.
Generation of recombinant proteins and polyclonal antisera. To identify the Bm86 ortholog in 
the I. scapularis genome, the Bm86 genes from R. microplus and I. ricinus were used for similarity and identity 
comparison against the I. scapularis genome, which is available from the NCBI database (XM_029991986.1). 
Two Bm86 homologs, Is86-1 and Is86-2, were PCR amplified using a template from the I. scapularis  genome37, 
cloned into the pGEM-T Easy Vector (Promega), sequenced, and deposited in the NCBI nucleotide database. 
The EGF-like domains within Is86-1 and Is86-2 were predicted according to published  data15, and further vali-
dated using the PROSITE server (https ://prosi te.expas y.org). Clones harboring either Is86-1 or Is86-2 were used 
as templates for further PCR amplification of EGF-1 and EGF-2, respectively, using primers containing restric-
tion sites (Table S1). EGF-3 was amplified from both clones. The PCR-amplified EGF domain products (EGF-1, 
-2, and -3) were subcloned into a pET28a expression vector. Heterologous expression of the three recombinant 
EGF-like domains was induced in BL21 (DE3) E. coli with 0.4 mM IPTG at 37 °C. The recombinant proteins, 
containing 6xHis-tag located at the N-terminus, were purified using ProBond Nickel-Chelating Resin (Thermo 
Fisher Scientific), dialyzed, and refolded in 50 mM Tris–HCl. Polyclonal antisera against each of the three recom-
binant domains were generated in mice as  described50. The antibody titers were assessed using an enzyme-linked 
immunosorbent assay (ELISA) and the specificity was evaluated using Western  blotting50.
Phylogenetic analysis. The protein sequences of Bm86 orthologs among hard and soft tick species were 
based on multiple sequence alignments generated with ClustalW. The phylogenetic tree was constructed using 
the maximum likelihood method with 1000 bootstrap replicates in MEGA7  software51.
Western blotting. Immunoblotting was performed as  described48. Briefly, the dissected guts of unfed ticks 
(~ 30 μg of total larval lysate, 5 nymphs/lane, 3 females/lane) and two-day fed ticks (~ 30 μg of female gut lysate/
lane, 2 nymphs/lane) were pooled, extracted and resolved by SDS-PAGE, and immunoblotted using antiserum 
(1:1,000) against Is86 homologs. The blots were developed by the addition of horseradish peroxidase (HRP)-
conjugated secondary antibodies (1:5,000 to 10,000), using the chemiluminescent immunoblotting detection 
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reagent (Thermo Scientific Inc.). Immunoblotting to confirm B. burgdorferi infection in mice was performed as 
 described48.
Active immunization with recombinant EGF domains and infection studies. For B. burgdor-
feri transmission experiments, mice were immunized with individual recombinant Is86 EGF-1, -2, or -3, as 
 detailed42,47. Briefly, 10 μg of recombinant protein was dissolved in 50 μl of phosphate-buffered saline (PBS), 
emulsified with 50 μl of complete (first injection) or incomplete (remaining two injections) Freund’s adjuvant, 
and subcutaneously administered into each mouse at 10-day intervals. As recombinant EGF proteins are rela-
tively pure (Fig. S1B), mice immunized with PBS and adjuvant served as the only control group. Two weeks after 
the second boost, groups of mice (3 mice/group) were infested with B. burgdorferi-infected I. scapularis nymphs 
(10 ticks/mouse). A portion of ticks was forcibly detached after 48 h of feeding, and others were collected when 
they dropped off after full repletion. The spirochete burdens in 48-h fed and replete ticks were assessed using 
qPCR. Ten days after tick feeding, mice were euthanized, and skin biopsy samples were collected to assess the 
spirochete burdens by qPCR.
For B. burgdorferi acquisition experiments, mice were immunized with recombinant EGF-1, -2, or -3, as 
described in the above paragraph. The mice were then infected with B. burgdorferi via intradermal needle inocu-
lation. Two weeks after inoculation, the mouse sera were collected and probed with B. burgdorferi lysates and 
immunoblotted to confirm infection, prior to infestation with naïve nymphs (15 ticks/mouse, 2 mice/group). 
Ticks were collected after 48 h of feeding and after full repletion. Spirochete burdens in the ticks were evaluated 
with qPCR, as described  previously42. Following the completion of tick feeding, murine skin samples were col-
lected to assess spirochete burdens using qPCR. In both infection studies, to monitor the progress of feeding, 
ticks were checked daily until all had detached from the mice. Detached ticks were collected and counted, and 
their engorgement weights were measured using a laboratory scale. Ticks were then allowed to molt, and their 
molting rates were calculated two months after repletion.
RNA interference and infection studies. RNA interference (RNAi) experiments targeting tick Is86-1 
and Is86-2 were conducted as  described42. Briefly, the targeted sequences in Is86-1 and Is86-2 were PCR ampli-
fied using T7 promoter sequence-containing primers (Table S1). A fragment of the GFP gene was amplified 
as a control. The dsRNAs were synthesized and purified using the MEGAscript RNAi Kit (Ambion). To assess 
whether the silencing of Is86 expression affects  B. burgdorferi  transmission by ticks, infected nymphs were 
microinjected with dsIs86 RNA (pooled dsRNAs targeting both homologs) or dsGFP RNA (5 µg/µl) using a 
microinjector (Eppendorf). After overnight incubation, the ticks were allowed to feed on naïve mice until full 
repletion (10 ticks/mouse). The ticks were collected and individually processed for the assessment of gene silenc-
ing, using primers that bind further upstream and downstream of the target dsRNA sequence (Table S1). Mouse 
skin samples were collected 10 days after tick feeding. Pathogen levels in the individual ticks and in murine 
tissues were evaluated by measuring the flaB  transcripts with qPCR and normalizing against tick and mouse 
β-actin, respectively.
Artificial membrane tick feeding system. An artificial membrane feeder was used to generate adult 
ticks from naïve and Borrelia-infected nymphs. The system was developed using published procedures as 
 detailed52. Although various B. burgdorferi sensu lato spirochetes can resist or remain sensitive to killing by the 
host complement, we had previously shown that commercial defibrinated bovine blood can used in our mem-
brane feeder system to study the acquisition and transmission of B. burgdorferi B31 strain. Briefly, defibrinated 
bovine blood was used, and the blood was changed every 12 to 14 h. Adult ticks (10 ticks/capsule) were placed 
on the artificial membrane feeding system, allowed to feed on bovine blood until partial repletion (~ 48 h), and 
collected to process for further analysis. Adult ticks were used for Is86 expression and immunoprecipitation 
experiments.
Immunoprecipitation. Native Is86 was immunoprecipitated from adult tick guts using the Protein G 
Immunoprecipitation Kit (Sigma-Aldrich) as  detailed53. Briefly, a RIPA buffer (Sigma) served to extract a mid-
gut lysate from 10 ticks (~ 10 µg), which was then incubated with the pooled EGF-1, -2, and -3 antisera. The 
immunoprecipitated products were resolved using SDS-PAGE and either stained with Sypro Ruby or probed 
with pooled EGF antisera.
Confocal microscopy. Confocal microscopy was performed as  detailed42. Unfed tick guts were fixed in 
4% paraformaldehyde at 4 °C overnight, then rinsed three times with PBS and permeabilized with acetone for 
10 min. The tick tissues were blocked with 5% normal goat serum in PBS for 1 h at room temperature (RT) and 
then incubated with pooled EGF antisera at 4  °C overnight. After three washes with PBST (PBS with 0.05% 
Tween20), the tissues were incubated with Alexa Fluor 488-labelled goat anti-mouse IgG (Molecular Probes) for 
1 h at room temperature, and the nuclei were stained with DAPI dye (Invitrogen) and imaged by a LSM510 laser 
confocal microscope (Zeiss), using the same fluorescence threshold setup for both naïve and Borrelia-infected 
samples as described  previously42.
Statistical analysis. The data were presented as median values with error bars indicating 95% confidence 
intervals (CI), or as mean values with error bars indicating the standard deviation (SD) or the standard error of 
the mean (SEM). Statistical differences were measured by using the non-parametric Mann Whitney two-tailed 
test or two-way ANOVA with Bonferroni post-tests using Prism 7 (GraphPad Software, Inc.).
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